Transcriptional Regulation of CD4+ T Cell Differentiation and Diversified Memory
CD4 T 细胞分化和多样化记忆的转录调控
基本信息
- 批准号:10714458
- 负责人:
- 金额:$ 50.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-07 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAutoimmune DiseasesB-LymphocytesBACH2 geneBLR1 geneBiological ModelsCD4 Positive T LymphocytesCell Differentiation processCellsChromatinCommunicable DiseasesComplexDataDevelopmentGenerationsGenesGoalsHelper-Inducer T-LymphocyteHumoral ImmunitiesIL2RA geneImmune responseImmunizationInflammatoryInterleukin-6KnowledgeMaintenanceMapsMemoryModelingMolecularMusPathway interactionsPopulationPositioning AttributeProcessProteinsRegulationReporterResearchRoleStructure of germinal center of lymph nodeT cell differentiationT cell responseT memory cellT-Lymphocyte SubsetsTranscriptional RegulationVaccinesWorkarmcytokinecytotoxicdesigninfectious disease treatmentintraperitonealmemory CD4 T lymphocytemouse modelnew pandemicnovelnovel markerpandemic potentialpandemic responseprogrammed cell death protein 1public health relevancereceptorresponsesingle-cell RNA sequencingtranscription factortranscriptometranscriptome sequencingvaccine developmentvaccine strategy
项目摘要
Project Summary
T follicular helper (Tfh) cells are essential for germinal center (GC) responses and long-term
humoral immunity. However, the complex regulation that determines the differentiation of Tfh cells, in
particular, the initial CXCR5– versus CXCR5+ CD4+ T cell differentiation, the developmental progression
of CXCR5+CD4+ T cells to become GC-Tfh cells, and the generation of follicular helper-like memory
CD4+ T cells expressing CXCR5, are still not fully understood. Our proposal aims to fill in these
knowledge gaps with long-term goals to identify novel genes/pathways underlying the CD4+ T cell
differentiation.
In our preliminary studies, we have discovered a novel network engaging various
factors/pathways that fine-tunes CXCR5+ versus CXCR5– CD4+ T cell differentiation and regulates the
generation of cytotoxic CD4+ T cells in the early stage of CD4+ T cell response. By combining RNA-seq,
ATAC-seq, and single cell RNA-seq, our preliminary data also suggest that the PD-1+CXCR5+ pre-Tfh
cells undergo substantial further differentiation to become PD-1hiCXCR5hi GC-Tfh cells. Additionally, we
have generated novel “fate-mapping” reporter mice that will allow us to track the varied CXCR5– and
CXCR5+ memory CD4+ T cells. Thus, in this application, we aim to dissect the molecular underpinning
of the early stage CXCR5+ versus CXCR5– CD4+ T cell differentiation as well as to elucidate the
mechanisms underlying the pre- to GC-Tfh differentiation and the generation of diversified CD4+ T cell
memory.
Our work will have a profound impact on the field of CD4+ T cell differentiation. The research will
not only shed new light on our understanding of the mechanisms underlying the multiple steps of Tfh
cell differentiation but also establish new model systems for memory CD4+ T cell studies. This proposal
has the potential to provide important knowledge on how to control both the humoral and the cellular
arms of the CD4+ T cell response to aid vaccine development for new pandemic threats and help the
treatment of infectious diseases and autoimmune disorders.
项目概要
滤泡辅助 T (Tfh) 细胞对于生发中心 (GC) 反应和长期反应至关重要
体液免疫。然而,决定 Tfh 细胞分化的复杂调控,在
特别是,初始 CXCR5– 与 CXCR5+ CD4+ T 细胞分化、发育进程
CXCR5+CD4+ T 细胞成为 GC-Tfh 细胞,以及滤泡辅助记忆的产生
表达 CXCR5 的 CD4+ T 细胞仍未完全了解。我们的建议旨在填补这些
与识别 CD4+ T 细胞潜在新基因/通路的长期目标之间的知识差距
差异化。
在我们的初步研究中,我们发现了一个新颖的网络,涉及各种
微调 CXCR5+ 与 CXCR5– CD4+ T 细胞分化并调节
在 CD4+ T 细胞反应的早期阶段产生细胞毒性 CD4+ T 细胞。通过结合RNA-seq,
ATAC-seq 和单细胞 RNA-seq,我们的初步数据也表明 PD-1+CXCR5+ pre-Tfh
细胞经历进一步实质性分化,成为 PD-1hiCXCR5hi GC-Tfh 细胞。此外,我们
已经培育出新型“命运图谱”报告小鼠,这将使我们能够追踪不同的 CXCR5 – 和
CXCR5+ 记忆 CD4+ T 细胞。因此,在本应用中,我们的目标是剖析分子基础
早期 CXCR5+ 与 CXCR5-CD4+ T 细胞分化的比较,并阐明
GC-Tfh 前分化和多样化 CD4+ T 细胞生成的机制
记忆。
我们的工作将对 CD4+ T 细胞分化领域产生深远的影响。该研究将
不仅让我们对 Tfh 多个步骤背后的机制有了新的认识
细胞分化,还为记忆 CD4+ T 细胞研究建立新的模型系统。这个提议
有潜力提供有关如何控制体液和细胞的重要知识
CD4+ T 细胞反应的武器,有助于针对新的大流行威胁的疫苗开发,并帮助
治疗传染病和自身免疫性疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hui Hu其他文献
Hui Hu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hui Hu', 18)}}的其他基金
Transcriptional Regulation of CD4+ T Cell Differentiation and Diversified Memory
CD4 T 细胞分化和多样化记忆的转录调控
- 批准号:
10741301 - 财政年份:2022
- 资助金额:
$ 50.79万 - 项目类别:
Hypertensive Disorders of Pregnancy and Early Risk of Maternal CVD: Influence of the External Exposome
妊娠期高血压疾病和孕产妇心血管疾病的早期风险:外部暴露的影响
- 批准号:
10645046 - 财政年份:2021
- 资助金额:
$ 50.79万 - 项目类别:
Hypertensive Disorders of Pregnancy and Early Risk of Maternal CVD: Influence of the External Exposome
妊娠期高血压疾病和孕产妇心血管疾病的早期风险:外部暴露的影响
- 批准号:
10523580 - 财政年份:2021
- 资助金额:
$ 50.79万 - 项目类别:
Hypertensive Disorders of Pregnancy and Early Risk of Maternal CVD: Influence of the External Exposome
妊娠期高血压疾病和孕产妇心血管疾病的早期风险:外部暴露的影响
- 批准号:
10214088 - 财政年份:2021
- 资助金额:
$ 50.79万 - 项目类别:
Hypertensive Disorders of Pregnancy and Early Risk of Maternal CVD: Influence of the External Exposome
妊娠期高血压疾病和孕产妇心血管疾病的早期风险:外部暴露的影响
- 批准号:
10414064 - 财政年份:2021
- 资助金额:
$ 50.79万 - 项目类别:
Hypertensive Disorders of Pregnancy and Early Risk of Maternal CVD: Influence of the External Exposome
妊娠期高血压疾病和孕产妇心血管疾病的早期风险:外部暴露的影响
- 批准号:
10771766 - 财政年份:2021
- 资助金额:
$ 50.79万 - 项目类别:
Regulation of Tfh cell differentiation and humoral immunity
Tfh细胞分化和体液免疫的调节
- 批准号:
10165471 - 财政年份:2017
- 资助金额:
$ 50.79万 - 项目类别:
Transcriptional regulation of T cell quiescience and activation
T 细胞静止和激活的转录调控
- 批准号:
8872018 - 财政年份:2012
- 资助金额:
$ 50.79万 - 项目类别:
Negative regulatory pathways in T cell quiescence and T cell response
T 细胞静止和 T 细胞反应中的负调控途径
- 批准号:
8549950 - 财政年份:2012
- 资助金额:
$ 50.79万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 50.79万 - 项目类别:
Operating Grants
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 50.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 50.79万 - 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
- 批准号:
23K14742 - 财政年份:2023
- 资助金额:
$ 50.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
- 批准号:
10593224 - 财政年份:2023
- 资助金额:
$ 50.79万 - 项目类别:
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 50.79万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 50.79万 - 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
- 批准号:
23K06589 - 财政年份:2023
- 资助金额:
$ 50.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 50.79万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 50.79万 - 项目类别:














{{item.name}}会员




